Form 8-K - Current report:
SEC Accession No. 0001193125-24-217444
Filing Date
2024-09-12
Accepted
2024-09-12 06:01:54
Documents
20
Period of Report
2024-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878008d8k.htm   iXBRL 8-K 40439
2 EX-1.1 d878008dex11.htm EX-1.1 276034
3 EX-4.1 d878008dex41.htm EX-4.1 57874
4 EX-5.1 d878008dex51.htm EX-5.1 13364
5 EX-99.1 d878008dex991.htm EX-99.1 10570
9 GRAPHIC g878008dsp80.jpg GRAPHIC 1916
10 GRAPHIC g878008dsp80b.jpg GRAPHIC 7756
11 GRAPHIC g878008dsp83.jpg GRAPHIC 11313
  Complete submission text file 0001193125-24-217444.txt   661165

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tern-20240910.xsd EX-101.SCH 2862
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tern-20240910_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tern-20240910_pre.xml EX-101.PRE 11715
22 EXTRACTED XBRL INSTANCE DOCUMENT d878008d8k_htm.xml XML 3782
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 241293806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)